Health
Using peanuts to cure potentially deadly allergy
Publish Date: Jan 30, 2014
Using peanuts to cure potentially deadly allergy
Peanut allergy affects about one in fifty children
  • mail
  • img
newvision

PARIS - Doctors said Thursday they could treat peanut allergy by feeding children the very thing their bodies reject, so building tolerance that could save a life in case of accidental ingestion.

Small doses of peanut powder taken over several months seemed to induce tolerance in children with the potentially deadly allergy, a research team wrote Wednesday in The Lancet medical journal.

After six months of treatment, dubbed oral immunotherapy or OIT, 84-91 percent of the children in a trial could safely tolerate daily doses of 800 mg (0.03 ounces) of peanut powder -- the equivalent of about five peanuts, wrote the team.

This was 25 times the amount they could tolerate before the therapy, and much larger than any accidental dose is likely to ever be.

"The treatment allowed children with all severities of peanut allergy to eat large quantities of peanuts, well above the levels found in contaminated snacks and meals, freeing them and their parents from the fear of a potentially life threatening allergic reaction," said study leader Andrew Clark from Cambridge University Hospitals.

"The families involved in this study say that it has changed their lives dramatically."

The trial involved 99 allergic children aged seven to sixteen.

One in five of the kids receiving OIT reported "adverse events" -- mostly mild itching of the mouth, the authors said.

They stressed that people should not try the treatment at home as more research was needed.

Peanut allergy affects about one in fifty children and is the most common cause of fatal food allergy reactions, said a press statement. About 10 million people around the world are allergic to peanuts.

Symptoms vary from mild to severe, from swollen lips or shortness of breath to anaphylactic shock, which can be fatal.

While "exceptionally promising", the method remains experimental, Matthew Greenhawt from the University of Michigan Food Allergy Center wrote in a comment also carried by The Lancet.

"It is unknown if OIT can produce lasting tolerance," he wrote.

AFP

The statements, comments, or opinions expressed through the use of New Vision Online are those of their respective authors, who are solely responsible for them, and do not necessarily represent the views held by the staff and management of New Vision Online.

New Vision Online reserves the right to moderate, publish or delete a post without warning or consultation with the author.Find out why we moderate comments. For any questions please contact digital@newvision.co.ug

  • mail
  • img
blog comments powered by Disqus
Also In This Section
Condoms
Ugandan MPs have been inundated with complaints that many condoms on sale are too small, warning the problem is a blow to the fight against AIDS....
New super-thin, skin-like condom being developed
The billionaire philanthropist says progress is being made on developing a "next-generation" ultra-thin, skin-like condom that could offer better sexual pleasure,...
Students push for Tobacco Control Bill passing
Students from five universities are petitioning parliament to pass the tobacco control bill, arguing that it has stayed too long on the shelf....
Mulago Hospital improves patients’ diet
Uganda’s national referral health facility Mulago Hospital has made adjustments to the meals it serves its in-patients, with a special diet introduced....
Obama: Ebola crisis
President Barack Obama issues a global call to action to fight the Ebola epidemic, warning the deadly outbreak was "spiraling out of control"....
200 Ugandan patients for sickle cell drug trial
At least 200 patients are to take part in a clinical trial for a more effective drug used to treat sickle cell anaemia....
Should bride price be made optional?
Yes
No
Can't Say
follow us
subscribe to our news letter